Similar articles for PMID: 28851700

Year	Number of Results
2002	1
2003	1
2004	1
2006	2
2007	2
2008	2
2009	1
2011	2
2012	1
2013	4
2014	1
2015	9
2016	9
2017	13
2018	16
2019	16
2020	4
2021	1
2022	1

1

Model-based projection of health and economic effects of screening for hepatitis C in Canada.

Wong WWL, Erman A, Feld JJ, Krahn M. Wong WWL, et al. CMAJ Open. 2017 Aug 25;5(3):E662-E672. doi: 10.9778/cmajo.20170048. CMAJ Open. 2017. PMID: 28851700 Free PMC article.

2

Cost-effectiveness of screening for hepatitis C in Canada.

Wong WWL, Tu HA, Feld JJ, Wong T, Krahn M. Wong WWL, et al. CMAJ. 2015 Feb 17;187(3):E110-E121. doi: 10.1503/cmaj.140711. Epub 2015 Jan 12. CMAJ. 2015. PMID: 25583667 Free PMC article.

3

Economic model of a birth cohort screening program for hepatitis C virus.

McGarry LJ, Pawar VS, Panchmatia HR, Rubin JL, Davis GL, Younossi ZM, Capretta JC, O'Grady MJ, Weinstein MC. McGarry LJ, et al. Hepatology. 2012 May;55(5):1344-55. doi: 10.1002/hep.25510. Epub 2012 Mar 18. Hepatology. 2012. PMID: 22135116

4

Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.

Kim KA, Chung W, Choi HY, Ki M, Jang ES, Jeong SH. Kim KA, et al. Liver Int. 2019 Jan;39(1):60-69. doi: 10.1111/liv.13930. Epub 2018 Aug 10. Liver Int. 2019. PMID: 29998565

5

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A. Shepherd J, et al. Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047 Free article. Review.

6

Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States.

Chaillon A, Rand EB, Reau N, Martin NK. Chaillon A, et al. Clin Infect Dis. 2019 Nov 13;69(11):1888-1895. doi: 10.1093/cid/ciz063. Clin Infect Dis. 2019. PMID: 30689769 Free PMC article.

7

Assessing the cost-effectiveness of hepatitis C screening strategies in France.

Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, Cossais S, Roudot-Thoraval F, Canva V, Mathurin P, Dhumeaux D, Yazdanpanah Y. Deuffic-Burban S, et al. J Hepatol. 2018 Oct;69(4):785-792. doi: 10.1016/j.jhep.2018.05.027. Epub 2018 Jul 1. J Hepatol. 2018. PMID: 30227916 Free article.

8

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U. Sroczynski G, et al. Eur J Public Health. 2009 Jun;19(3):245-53. doi: 10.1093/eurpub/ckp001. Epub 2009 Feb 5. Eur J Public Health. 2009. PMID: 19196737 Review.

9

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K. Thompson Coon J, et al. Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340. Health Technol Assess. 2007. PMID: 17767898 Free article. Review.

10

Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting.

Girardin F, Hearmon N, Castro E, Negro F, Eddowes L, Gétaz L, Wolff H. Girardin F, et al. Clin Infect Dis. 2019 Nov 13;69(11):1980-1986. doi: 10.1093/cid/ciz088. Clin Infect Dis. 2019. PMID: 30715266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed